Nucleate Boston and Sanofi’s NA R&D Scientific Relations & Initiatives team are hosting a hybrid event that will dive into the collaboration between pharma companies and early-stage biotech startups. The evening will feature a panel discussion with industry leaders and successful Nucleate-affiliated startups, highlighting the value of partnerships and the potential benefits for biotech ventures. 

Attendees will gain insights into advancing innovative therapies and technologies, followed by networking opportunities to foster new connections in the biotech ecosystem.

The event will occur on November 19th, 2024 from 5-7pm EST. Visit the registration page to sign up for the event.